Trials / Completed
CompletedNCT00353054
Effect of Calcium/Vitamin D Supplementation on Body Weight and Fat Loss.
A Double-Blind, Randomized, Placebo Controlled, Parallel Group Study to Evaluate the Effect of Calcium/Vitamin D Supplementation (Caltrate 600+ D) on Body Weight and Fat Loss in Overweight and Obese Individuals on a Weight-Reducing Program.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 80 (planned)
- Sponsor
- Laval University · Academic / Other
- Sex
- Female
- Age
- 30 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study was to assess the effect of calcium/vitamin D supplementation (Caltrate 600 +D®) on body weight loss during a weight-reducing program
Detailed description
The effect of a calcium supplementation on body weight loss is inconclusive and some studies have suggested that adequate calcium intake can have a favourable effect on some metabolic variables. The objectives of this study were to evaluate the impact of (Caltrate 600 + D ®) on body composition and various indicators of metabolic health in overweight and obese females characterised by a usual low daily calcium intake, on a weight-reducing program. The main hypotheses of this study were: * Caltrate 600 +D® increases body weight and fat mass losses of individuals on a weight-reducing program. * Caltrate 600 +D® improves the metabolic profile of these subjects, independently of variations promoted by body fat loss.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Caltrate® 600 + D | |
| BEHAVIORAL | Weight loss intervention |
Timeline
- Start date
- 2003-01-01
- Completion
- 2005-07-01
- First posted
- 2006-07-17
- Last updated
- 2006-07-17
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00353054. Inclusion in this directory is not an endorsement.